Description: Panelists discuss the methods HMOs employ to measure their providers' quality of care, outcomes, compliance with best practice guidelines, and cost control. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: Physicians and hospital representatives will discuss their views on health care reform, insurance companies and managed care. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This session discusses affordable health care including cost drivers, trends, the uninsured, federal funding and state initiatives. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 109

Description: Panelists discuss the current trend environment and estimating future trend. From the Record of the SOA, Vol. 29, No. 2, Session 52

Description: This session from the 2003 SOA Orlando Meeting presents various predictive models, evaluation methodologies, control groups, current and potential uses for predictive modeling and issues surrounding implementation of a predictive modeling process. From the Record of the Society of Actuaries, Volume 29, No. 3.

Description: Panelists discuss opportunities to improve medical cost trends through underwriting, healthcare benefit designs, contracting, network management, claims operations, and medical management. From the Record of the Society of Actuaries, Vol. 31, No. 2, Session 40

Description: This 1981 session focused on cost containment programs for health care in Canada and the US. Topics included: 1. Possible changes - improved plan design 2. Ways to stimulate change - market forces vs. regulation 3. Untapped cost control-health education for employees - health lifestyles & disease prevention 4. Information sources From Record of Society of Actuaries, Vol. 7, No. 2.

Description: The article describes the insurance industry's preparation for pandemic events and the public finance response.

Description: This session describes the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. We will walk through the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. We will also walk through some sample models that illustrate how costs for emerging technologies and treatments can be modeled.